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Heme is of significant importance in iron nutrition and in systemic iron metabolism. The crux 
of the matter is that while much is known about non-heme metabolism, the vectorial import 
of exogenous porphyrin macromolecules into the enterocyte and possibly into blood 
circulation is still speculative.  The inhibitory effect of calcium on heme iron absorption has 
been previously reported in the literature. This paper postulates that the gastrointestinal Ca 
transporter, TRPV6 might be a putative transporter of heme and that it is the mechanism of 
reduced heme absorption in the presence of Ca. The hypothesis needs to be investigated in 
vitro and in vivo with targeted TRPV6 deletion models to explore the nature of the 
competition of heme uptake by Ca. Studies are required to characterise fully this function in 
the gut and in systemic metabolism. If the hypothesis is proven, modulators of TRPV6 
expression could have clinical implications in the management of heme-induced disorders. 
 
Introduction 
Transport of heme at both luminal and endogenous levels are quantitatively of vital 
importance in iron metabolism. Systemic transcellular heme transit is carried out by 
proteins or receptors such as LRP or HRG1 that are not expressed in the duodenum (1, 2). 
Consequently, the enterocyte vectorial apical heme transporter remains elusive and 
enigmatic in iron metabolism research since HCP1 transports folate with a higher affinity (3, 
4). There is considerable evidence that the duodenal transporter of heme porphyrin 
proteins has higher transport kinetics than DMT1, the inorganic iron counterpart (5). It is 
presumably due, in part, to heme non-reactivity with luminal inhibitory dietary ligands. 
Consequently, heme iron sources from animal products are quantitatively of higher 
bioavailability than non-heme iron and can provide a relatively larger amount of iron to the 
body (6). The disparate haem and non-haem transport proteins are, however, paradoxically 
inhibited by calcium in models of both animal and human studies (7, 8). Inconsistencies or 
disparity of inhibition of Ca on iron absorption have in recent times been attributed to dose, 
time duration, and the Ca sources used in various experiments (8-10).  
From previous studies towards a hypothesis 
Heme and non-heme iron in luminal food matrix maintain distinct, discrete identities of 
which the former assumes supremacy of higher bioavailability only to culminate ultimately 
in a common pool of inorganic iron in the cytosol of the enterocytes. While there is evidence 
of a delayed systemic response to heme absorption when compared with non-heme iron 
(24), its existence as heme moieties after absorption seems to end in the cytosol. Evidence 
has shown that calcium exerts an inhibition of heme absorption at the initial mucosal uptake 
step rather than at the basolateral transfer into circulation (25).  Although heme absorption, 
in a similar pattern to that of non-heme occurs in the duodenum, there is a decreasing 
  
gradient along the lower gastrointestinal tract (19).  In contrast, however, solubility of 
heme, unlike that of non-heme exhibits an increasing gradient with increasing pH of the 
lower gut. Consequently, higher heme absorption by transporters in the lower gut would 
benefit additionally from longer resident and transit time. Calcium has been shown to 
inhibit heme-induced cytotoxicity and carcinogenesis (20, 21) in the colon. TRPV6 is 
expressed in the duodenum and possibly in the lower section of the gastrointestinal tract. 
The hypothesis 
In light of the inhibitory effect of Ca on heme absorption, it is herein hypothesized that 
TRPV6, the Ca transporter, possibly transports heme and is inhibited by Ca. That, the 
putative function of TRPV6 as a heme transporter is competitively inhibited by heme.  This 
hypothesis seems plausible because heme was demonstrated to bind and inhibit 
mammalian calcium-dependent Slo1 BK channels in the brain of the rat (26). These channels 
possess the conserved heme-binding sequence motif (CXXCH) (16, 27). The physiological 
consequences of this finding will have ramifications for other tissues and organs that 
express TRPV6 and possibly other calcium channels as well. What is particularly fascinating 
is the evidence that the G185R mutation turns DMT1, the non-heme membrane iron 
transporter into a calcium channel and this was ascribed possibly to a selective advantage of 
Ca flux to extend the lifespan of microcytic (mk) mice and Belgrade rats (28).  Of significance 
importance, also, is the evidence that alludes to efficient heme uptake in the Belgrade rats 
when strain differences were eliminated in the control group (29, 30). Although the binding 
motif is not conserved in TRPV6, luminal competitive binding and interactions of calcium 
and heme might account for the mechanism of the inhibition on the transporter. While 
hemin carries a net positive charge, it did not induce electrochemical current in oocytes (4), 
the mechanism of inhibition could possibly be by coupling and binding to Ca in the lumen 
that consequently inactivates TRPV6. An alternative scenario is that heme-calcium complex 
induces conformational changes to the configuration of Ca transporter. 
Testing the hypothesis 
 Studies are warranted using radio-labelled heme to investigate the kinetics and the nature 
of the inhibition of heme transport by the calcium channel. Studies will examine heme 
transport in cell cultures and investigate if amino-ethoxydiphenyl borate (2-APB), the 
inhibitor of Ca transporter, would diminish heme uptake in cells. In vitro binding 
characteristics and kinetics of binding of heme-calcium complexes will also be investigated. 
Calcium channel knockout mice, Belgrade rats, L-type Ca channel blockers, transgenic 
expression of TRPV6 and radio-labelled heme are valuable tools to employ in such studies. 
Heme absorption/uptake and competition of uptake by Ca will be carried out in these 
animal models. Techniques of immunohistochemistry and confocal microscopy will be 
employed to localise TRPV6 in different sections of the gastrointestinal tract. It is also 
important to decipher the intricacies and complexity of interactions involved in the 
  
pleiotropic transporter functions of calcium channels which upon mutational transformation 
of DMT1 also assume a gain-of-function heme transporting role.  
Implications of the hypothesis and conclusions 
The hypothesis as proposed will be attested if heme absorption is inhibited by TRPV6 
inhibitor, 2-APB and heme absorption is enhanced in calcium channel knockout mice and 
belgrade rats. The validation of the hypothesis will advance knowledge in the mechanism of 
heme absorption in the gastrointestinal tract. At the public nutrition level, the use of 
calcium supplements and rich sources of Ca in the diets will need to be moderated for 
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